Xcel Brands, Inc. — Q1 2024 Form 10-Q
Business context and period. The filing covers the three months ended March 31, 2024; the financial statements are unaudited. Xcel is a branded consumer-products and media company whose revenue is primarily from licensing. Following its 2023 shift from a wholesale/licensing hybrid to a “licensing plus” model, it exited wholesale and direct-to-consumer product sales. Its portfolio includes wholly owned brands and interests in Longaberger, Isaac Mizrahi and ORME Live. ORME launched in Q1 2024; the TowerHill by Christie Brinkley brand was planned to launch by the end of May 2024.
Financial performance
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Net revenue | $2.18 million | $6.05 million |
| Net licensing revenue | $2.18 million | $2.22 million |
| Net product sales | $0 | $3.83 million |
| Gross profit | $2.18 million | $3.36 million |
| Operating loss | $6.20 million | $5.91 million |
| Net loss attributable to Xcel shareholders | $6.29 million | $5.64 million |
| Basic and diluted loss per share | $0.31 | $0.29 |
| Net cash used in operating activities | $2.61 million | $2.92 million |
Cost of goods sold was zero after the exit from product sales, so the reported gross profit equaled licensing revenue; this is not directly comparable with the prior-year product-and-licensing mix. Direct operating expenses fell to $3.96 million from $6.96 million. The company reported $2.30 million in impairment charges and $1.59 million in depreciation and amortization. Non-GAAP net loss was $1.82 million versus $3.55 million; Adjusted EBITDA was negative $1.59 million versus negative $3.23 million. These are company-defined non-GAAP measures and should be considered alongside GAAP results.
Financial position and liquidity
- At March 31, 2024, cash and cash equivalents were $1.55 million, down from $3.00 million at year-end. Restricted cash of $0.74 million was held as collateral for a lease letter of credit; total cash, cash equivalents and restricted cash were $2.29 million.
- Current assets were $6.07 million and current liabilities were $6.18 million. Management’s adjusted working-capital measure was $2.1 million, down from $2.9 million at December 31, 2023.
- Term-loan principal was $5.0 million, with $1.0 million classified as current and $3.75 million net long-term debt after unamortized finance costs. The loan matures in October 2028; quarterly principal installments are $250,000. The loan is secured by substantially all assets of certain subsidiaries, subject to stated exceptions. The company reported compliance with its covenants.
- Operating lease liabilities totaled $4.97 million. In January, Xcel agreed to sublease its former 1333 Broadway offices through October 2027; it recorded related non-cash impairment charges. A new office lease commenced in April 2024.
- March’s public offering and insider/director private placement raised approximately $1.9 million net and issued 3.58 million shares. The offering also included warrants for up to 182,952 shares.
Changes, outlook and key risks
- Year-over-year changes: Revenue declined primarily because product sales ended; licensing revenue was essentially flat. Lower staffing and overhead reduced direct operating expenses, but higher impairment charges and interest expense contributed to a larger GAAP net loss.
- Management outlook: Xcel says the 2023 restructuring is expected to deliver approximately $15 million in annualized cost savings versus its prior model; it had reported approximately $6 million lower annualized payroll costs and $9 million lower operating expenses at year-end 2023. Management expects cash and future operating cash flows to cover operating needs, debt service and capital spending for at least 12 months after filing, and says the going-concern uncertainty identified at March 31 has been alleviated. No specific revenue or earnings guidance is provided.
- Liquidity caveat: Q1 included a $6.3 million shareholder-attributable loss, $2.6 million operating cash outflow and $1.6 million unrestricted cash balance. The filing says these conditions initially raised going-concern uncertainty; management’s conclusion depends on the restructuring, financing and expected future cash flows.
- Revenue concentration: Qurate generated $1.61 million, or about 59% of Q1 revenue, compared with 25% a year earlier. Qurate receivables were $1.3 million, or 37% of net receivables, at quarter-end.
- Contingencies and subsequent events: In April, Xcel amended its Isaac Mizrahi/IM Topco arrangements. If specified royalty thresholds are missed, or certain payments are not made, Xcel may have to transfer 12.5 percentage points of its IM Topco interest to WHP, reducing its stake from 30% to 17.5%. Xcel paid $100,000 in April toward the $375,000 payment balance disclosed at March 31. The company also faces a dispute with Lori Goldstein over earn-out and alleged contract matters; Xcel commenced arbitration and terminated related agreements on May 2, and negotiations may include disposition of the brand and related assets. No definitive settlement terms were agreed as of the filing date.
- Controls and market risks: Management concluded disclosure controls were ineffective at March 31 because of a material weakness tied to delays in obtaining audited financial statements for an equity-method investee. The filing cites inflation, consumer demand, fashion trends, retailer consolidation and dependence on licensees and business partners as risks.
Important facts for investors to verify
- Whether operating cash flow improves enough to support the company’s 12-month liquidity outlook and term-loan payments.
- Progress against the projected cost savings and whether licensing revenue can grow or remains concentrated in Qurate.
- IM Topco royalty performance, required payments and the potential reduction in Xcel’s ownership interest under the April amendments.
- Outcome and financial implications of the Lori Goldstein arbitration and negotiations.
- Remediation of the material weakness and timely completion of the equity-method investee’s audited financial statements.
- Potential dilution from the March share issuance, outstanding options and warrants, and future equity-plan awards.